BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 16432591)

  • 1. Prevalence of extended-spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital.
    El-Khizzi NA; Bakheshwain SM
    Saudi Med J; 2006 Jan; 27(1):37-40. PubMed ID: 16432591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of extended-spectrum b-lactamases in members of the family enterobacteriaceae at a teaching hospital, Riyadh, Kingdom of Saudi Arabia.
    Babay HA
    Saudi Med J; 2002 Feb; 23(2):186-90. PubMed ID: 11938396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
    Kader AA; Kumar AK
    Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates.
    Al-Zarouni M; Senok A; Rashid F; Al-Jesmi SM; Panigrahi D
    Med Princ Pract; 2008; 17(1):32-6. PubMed ID: 18059098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals.
    Ko KS; Lee MY; Song JH; Lee H; Jung DS; Jung SI; Kim SW; Chang HH; Yeom JS; Kim YS; Ki HK; Chung DR; Kwon KT; Peck KR; Lee NY
    Diagn Microbiol Infect Dis; 2008 Aug; 61(4):453-9. PubMed ID: 18482815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
    Hirakata Y; Matsuda J; Miyazaki Y; Kamihira S; Kawakami S; Miyazawa Y; Ono Y; Nakazaki N; Hirata Y; Inoue M; Turnidge JD; Bell JM; Jones RN; Kohno S;
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):323-9. PubMed ID: 16165001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia.
    Kader AA; Angamuthu K
    Saudi Med J; 2005 Jun; 26(6):956-9. PubMed ID: 15983682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae in Trakya University Hospital, Turkey.
    Akata F; Tatman-Otkun M; Ozkan E; Tansel O; Otkun M; Tugrul M
    New Microbiol; 2003 Jul; 26(3):257-62. PubMed ID: 12901421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at Armed Forces Hospital in Saudi Arabia.
    Ahmad S; Al-Juaid NF; Alenzi FQ; Mattar EH; Bakheet Oel-S
    J Coll Physicians Surg Pak; 2009 Apr; 19(4):264-5. PubMed ID: 19356348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended spectrum beta-lactamase producing organisms at the University Hospital of the West Indies.
    Nicholson AM; Gayle P; Roye-Green K
    West Indian Med J; 2004 Mar; 53(2):104-8. PubMed ID: 15199721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
    Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
    Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
    Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS
    J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
    Mendes RE; Rhomberg PR; Bell JM; Turnidge JD; Sader HS
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):415-25. PubMed ID: 19249175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Occurrence of alert pathogens in hospital environment. Part I. ESBL-producing enterobacteriaceae strains].
    Paluchowska P; Skałkowska M; Spelak A; Budak A
    Med Dosw Mikrobiol; 2012; 64(1):35-43. PubMed ID: 22808728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
    Ku YH; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent evolution and characterization of extended-spectrum beta-lactamase producing enterobacteria in the CHU of Nice (2005-2007)].
    Giraud-Morin C; Fosse T
    Pathol Biol (Paris); 2008; 56(7-8):417-23. PubMed ID: 18848404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden.
    Ostholm-Balkhed A; Tärnberg M; Nilsson M; Johansson AV; Hanberger H; Monstein HJ; Nilsson LE
    Scand J Infect Dis; 2010 Dec; 42(11-12):831-8. PubMed ID: 20608768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of extended-spectrum beta-lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as determined by the VITEK 2 and E test systems in a Kuwait teaching hospital.
    Jamal W; Rotimi VO; Khodakhast F; Saleem R; Pazhoor A; Al Hashim G
    Med Princ Pract; 2005; 14(5):325-31. PubMed ID: 16103698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
    Nijssen S; Florijn A; Bonten MJ; Schmitz FJ; Verhoef J; Fluit AC
    Int J Antimicrob Agents; 2004 Dec; 24(6):585-91. PubMed ID: 15555882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production.
    Yang JL; Wang JT; Lauderdale TL; Chang SC
    J Microbiol Immunol Infect; 2009 Aug; 42(4):310-6. PubMed ID: 19949754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.